Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy showed eplontersen met its co-primary endpoints. | March 27, 2023
A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena University Hospital, and .
OurCrowd Global Investor Summit Returns to Jerusalem themedialine.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themedialine.org Daily Mail and Mail on Sunday newspapers.